New Study Says You Can Slim Down and Save Your Bones—Here’s HowA low-calorie Mediterranean diet combined with exercise can help older women with metabolic syndrome lose weight and improve bone density.
Eli Lilly Challenges EMA Decision on Alzheimer’s Drug ApprovalEli Lilly seeks reexamination of its Alzheimer's drug, Keysunra, after EMA denied approval due to brain swelling concerns.
Gencurix’s New Test Spots Breast Cancer Mutation with 96.8% AccuracyGencurix's Droplex ESR1 Mutation Test shows 96.8% reliability for breast cancer diagnosis, aiding in early mutation detection and treatment.
This Common Vaccine May Help Protect Against Memory LossA study shows the shingles vaccine may lower dementia risk by nearly 20%, highlighting its potential benefits for older adults.
Moms-to-Be, Beware: This Common Condition May Raise Your Baby’s Autism RiskMaternal diabetes raises the risk of neurodevelopmental disorders in children, including autism and ADHD, according to a new study.
Zero-Calorie Sweeteners May Be Making You Hungrier, Study FindNew research indicates sucralose may increase appetite and contribute to weight gain, challenging the benefits of zero-calorie sweeteners.
Traditional African Foods Slash Inflammation—While Western Diets Fuel ItA study reveals that shifting to a traditional plant-based diet can reduce inflammation and improve immune function, countering Western dietary harm.
ADHD Isn’t Just Behavioral—It Could Be Physically Reshaping Your BrainA study links iron accumulation and brain damage to adult ADHD, revealing structural differences and potential neurodegeneration risks.
Roche’s $7.6 Billion Drug Just Hit a Wall—Here’s Why That MattersRoche's Ocrevus, a leading MS treatment, showed no added benefits at higher doses in trials, impacting future sales projections.
New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ YearsA study finds the ketogenic diet may slow epigenetic aging by over six years, highlighting its potential for health and weight management.
Wegovy Maker Strikes $1B Deal for Next-Gen Obesity TreatmentNovo Nordisk acquires global rights to Lexicon's obesity drug LX9851, aiming to enhance its position in the obesity treatment market.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug ShowdownEli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Trump’s Soda Button and 12-Can Habit: A Recipe for Trouble?Trump's eating habits, including fast food and soda, contrast with Biden's healthier choices, impacting their health and weight.
Novo Nordisk Just Bought the Next Big Thing in Weight LossNovo Nordisk secures global rights to Triple-G weight loss therapy through a licensing deal, targeting three hormones for better results.
Parkinson's Puzzle: Study Explains How PINK1 Gene Fights Cell DamageA study on the PINK1 gene reveals its role in Parkinson's disease, aiding mitochondrial protection and removal of damaged cells.
New Human Coronavirus Discovered in South Korea — Is It the Next Big Threat?South Korean researchers discovered a new coronavirus linked to an infant's liver dysfunction, differing from existing strains.
Boosting Cardiovascular Health Could Help Prevent Alzheimer's, Study FindsA study links higher Life’s Simple 7 scores for cardiovascular health to lower neurodegenerative disease biomarkers.
CagriSema Fails to Meet Expectations in Late-Stage Obesity Trial, but Still Beats PlaceboNovo Nordisk's CagriSema obesity treatment underperformed in trials, showing lower weight loss than anticipated compared to Wegovy.
Is 'Robus the New Name for Tesla’s Self-Driving Vans? Trademark Applications FiledTesla files trademark for "Robus" for electric vehicles and services, hinting at future RoboVan and robotaxi developments.
BMW's X7 Nishiki Lounge Concept: A Luxury SUV That Transcends Traditional DesignBMW unveils the X7 Nishiki Lounge concept, showcasing the pinnacle of luxury in SUV design and redefining high-end automotive art.
Hot Topics